36. Overview of research and therapy facilities for radiobiological experimental work in particle therapy. Report from the European Particle Therapy Network radiobiology group

/in , ,

Dosanjh M, Jones B, Pawelke J, Pruschy M, Sørensen BS. Overview of research and therapy facilities for radiobiological experimental work in particle therapy. Report from the European Particle Therapy Network radiobiology group. Radiother Oncol. 2018 Jul;128(1):14-18. doi: 10.1016/j.radonc.2018.03.008. Epub 2018 Apr 24. PMID: 29703500.

35. ENLIGHT Network. ENLIGHT: European network for Light ion hadron therapy

/in , ,

Dosanjh M, Amaldi U, Mayer R, Poetter R; ENLIGHT Network. ENLIGHT: European network for Light ion hadron therapy. Radiother Oncol. 2018 Jul;128(1):76-82. doi: 10.1016/j.radonc.2018.03.014. Epub 2018 Apr 3. PMID: 29625810.

34. Dosimetric and clinical impact of 3D vs. 2D planning in palliative radiotherapy for bone metastases

/in , ,

Pope K, Fitzpatrick D, Potter A, Holwell M, Wang L, Lau M, Levin W, McLean M, Balaura LZ, Bezjak A, Wong RK. Dosimetric and clinical impact of 3D vs. 2D planning in palliative radiotherapy for bone metastases. Support Care Cancer. 2013 Aug;21(8):2229-35. doi: 10.1007/s00520-013-1777-8. Epub 2013 Mar 16. PMID: 23503800.

33. Design and Implementation of a Distant-Learning Clinical Research Mentorship Program: The Accra-Toronto Collaboration

/in , ,

Vulpe H, Vanderpuyne V, Yarney J, Tosoni S, Ringash J, Kassam Z, Wong RKS. Design and Implementation of a Distant-Learning Clinical Research Mentorship Program: The Accra-Toronto Collaboration. JCO Glob Oncol. 2020 Jun;6:919-928. doi: 10.1200/JGO.19.00240. PMID: 32603189; PMCID: PMC7328115.

32. Radiation Oncology Fellowship: a Value-Based Assessment Among Graduates of a Mature Program

/in , ,

Ito E, Moraes FY, Ramotar M, Lunsky I, Soliman H, Catton CN, Kassam Z, Morton G, Tosoni S, Gospodarowicz M, Wong RKS, Liu FF, Chung PWM. Radiation Oncology Fellowship: a Value-Based Assessment Among Graduates of a Mature Program. J Cancer Educ. 2020 Jul 18. doi: 10.1007/s13187-020-01767-5. Epub ahead of print. PMID: 32683629.

31. Improving clinical research and cancer care delivery in community settings: evaluating the NCI community cancer centers program

/in , ,

Clauser SB, Johnson MR, O’Brien DM, Beveridge JM, Fennell ML, Kaluzny AD. Improving clinical research and cancer care delivery in community settings: evaluating the NCI community cancer centers program. Implement Sci. 2009 Sep 26;4:63. doi: 10.1186/1748-5908-4-63. PMID: 19781094; PMCID: PMC2764567.

30. The role of a public-private partnership: translating science to improve cancer care in the community

/in

O’Brien DM, Kaluzny AD. The role of a public-private partnership: translating science to improve cancer care in the community. J Healthc Manag. 2014 Jan-Feb;59(1):17-29. PMID: 24611422.

29. How vision and leadership shaped the U.S. National Cancer Institute’s 50-year journey to advance the evidence base of cancer control and cancer care delivery research

/in , ,

Kaluzny AD, O’Brien DM. How vision and leadership shaped the U.S. National Cancer Institute’s 50-year journey to advance the evidence base of cancer control and cancer care delivery research. Health Policy Open. 2020 Dec;1:100015. doi: 10.1016/j.hpopen.2020.100015. Epub 2020 Oct 13. PMID: 33073235; PMCID: PMC7550860.

28. Expanding global access to radiotherapy

/in , ,

Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TY, Milosevic M, O’Sullivan B, Rodin DL, Rosenblatt E, Van Dyk J, Yap ML, Zubizarreta E, Gospodarowicz M. Expanding global access to radiotherapy. Lancet Oncol. 2015 Sep;16(10):1153-86. doi: 10.1016/S1470-2045(15)00222-3. PMID: 26419354.

27. The Unique Issues With Brachytherapy in Low- and Middle-Income Countries

/in , ,

Grover S, Longo J, Einck J, Puri P, Brown D, Chino J, Mahantshetty U, Yashar C, Erickson B. The Unique Issues With Brachytherapy in Low- and Middle-Income Countries. Semin Radiat Oncol. 2017 Apr;27(2):136-142. doi: 10.1016/j.semradonc.2016.11.005. Epub 2016 Nov 10. PMID: 28325239; PMCID: PMC6661890.